Posts suggesting that the Irish subsidiary has been abandoned (it was only very recently established and may or may not be needed if partnership is announced) and that IPIX is back to 2011 status because we have no clinical trial running at this moment (IPIX has a phase 3 ready drug) is, IMO, asinine and clearly an attempt to plant seeds of doubt for personal gain. IPIX has a phase 3 ready drug with high need for those suffering oral mucositis and little actual competition for any relief (not to forget the possible anti inflammatory uses for B in other applications). Also, IPIX could announce a partnership or licensing deal at any time. Just as nothing is guaranteed, massive success could occur at any time. Consider the motivation for anyone posting.
(8)
(1)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links